Developing immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology.

Clinical Programs Phase
Hepatitis B Vaccine
Pre-ClinicalPhase 1Phase 2Phase 3
Phase
Asthma
Pre-ClinicalPhase 1Phase 2
Melanoma / Head & Neck Squamous Cell Carcinoma
Pre-ClinicalPhase 1/2
Multiple Malignancies
Pre-ClinicalPhase 1
Phase
Lung Cancer
Pre-Clinical